Ann: Australian institution to invest $2.7 million in OSL, page-13

You could say this is the best Oncosil has looked in a very long time , market cap should continue to head towards a $100 million. Quality changes to Oncosil team in the last year , recent institutional placement , EU MDR Approval due in the near term , Bullish T20 Changes , G-BA updates later this year , R & D refund expected to be around $ 1 million this year , make sense now why Oncosil management mentioned that they are very well funded to at least the end of the next calendar year.

It would be amazing if Oncosil can improve lives. A Take Over seems to be the main play here in the future but in the meantime creating value for investors is looking good. The Quarterly is going to be released within the next week or so which could see an improvement in revenue judging the Managing Directors comments that he is like what he is seeing go forward in terms of $$$.